No Data
No Data
Express News | BioLife Solutions Shares Are Trading Higher After Benchmark Ugpraded the Stock From Hold to Buy and Announced a $25 Price Target
Correction to BioLife Solutions Ratings
"BioLife Solutions Raised to Buy From Neutral by Benchmark" at 7:31 a.m. ET incorrectly stated that BioLife Solutions was raised to buy from Neutral. It was raised to buy from hold.
Express News | BioLife Solutions Inc : Craig-Hallum Raises Target Price to $23 From $21
BioLife Solns Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 30.21% Benchmark → $25 Upgrades Neutral → Buy 04/04/2024 14.58% Jefferies → $22 Initiates Cover
Benchmark Upgrades BioLife Solutions to Buy From Hold With $25 Price Target
BioLife Solutions (BLFS) has an average buy rating and a price target range of $20 to $30, according to analysts polled by Capital IQ.
Express News | BioLife Solutions Inc : Benchmark Raises to Buy